File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Era of direct acting antivirals in chronic hepatitis C: Who will benefit?

TitleEra of direct acting antivirals in chronic hepatitis C: Who will benefit?
Authors
Issue Date2015
Citation
World Journal of Hepatology, 2015, v. 7 n. 24, p. 2543-2550 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/224888

 

DC FieldValueLanguage
dc.contributor.authorFung, JYY-
dc.date.accessioned2016-04-18T03:33:48Z-
dc.date.available2016-04-18T03:33:48Z-
dc.date.issued2015-
dc.identifier.citationWorld Journal of Hepatology, 2015, v. 7 n. 24, p. 2543-2550-
dc.identifier.urihttp://hdl.handle.net/10722/224888-
dc.languageeng-
dc.relation.ispartofWorld Journal of Hepatology-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleEra of direct acting antivirals in chronic hepatitis C: Who will benefit?-
dc.typeArticle-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.authorityFung, JYY=rp00518-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.4254/wjh.v7.i24.2543-
dc.identifier.hkuros257546-
dc.identifier.volume7-
dc.identifier.spage2543-
dc.identifier.epage2550-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats